Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5741 participants
OBSERVATIONAL
2017-10-17
2019-09-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Design: Multicenter retrospective cohort study.
Assessed outcomes: Morbidity as defined by the Clavien-Dindo classification for surgical complications, the Comprehensive Complication Index® (CCI®) at discharge, at 3 months and at latest follow-up. Evolution of body mass index (BMI) will be also analyzed.
Hospital eligibility: High volume centers (\> 200 bariatric operations per year) from at least three continents, maintaining a prospective database, as well as having published previously critically on their outcome.
Study population: Adult patients who underwent primary minimally invasive (laparoscopic / robotic) Roux-en-Y gastric bypass or sleeve gastrectomy from 1st of June 2012 to 31st of May 2017.
Patient Exclusion criteria: detailed later.
Data collection Deadline: 1st September 2017 - 30 April 2018
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changes in Body Composition Following Bariatric Surgery
NCT02148068
Outcome of Bariatric Surgery in Patients With BMI Greater Than 60 .
NCT04663425
Impact of Bariatric and Metabolic Surgery on the Reduction of Premature Aging.
NCT06618846
Comparing the Benefits and Harms of Three Types of Weight Loss Surgery -- The PCORnet® Bariatric Study
NCT02741674
Study of Bariatric Surgery
NCT02857179
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In 2016, a first landmark study defining benchmark outcomes for liver resection was published in Annals of Surgery by a group of international authors invited and guided by our department. More recently, further surgical outcomes (liver transplantation, minimally invasive esophagectomy) have been benchmarked and have been accepted for publication.
Since laparoscopic bariatric surgery has become a standardized and widely performed procedure worldwide, quality assessment is of major importance. To identify the best possible outcomes (i.e. the benchmarks), data from high-volume centers (based on official IFSO criteria) in low risk patients will be analyzed. These benchmarks will serve as "optimal outcomes" for comparison with single center outcomes, high-risk patients and future developments.
Aim The primary aim is to define benchmark outcomes based on assessment of post procedural complications according to the Clavien-Dindo classification for surgical complications and the comprehensive complication index CCI™ at discharge and at 90-days. The CCI® expresses morbidity on a continuous numeric scale from 0 (no complications) to 100 (death) by weighing all postoperative complications according to the Clavien-Dindo classification for their respective severity. Secondary outcome measure are patient survival and excess BMI loss (EBMIL).
Data Security This multicenter international study is designed to harvest prospectively collected retrospective data via an encrypted (i.e. Secure Sockets Layer (SSL) protocol) online platform (https://bbenchmarks.org/) that meets Food and Drug Administration (FDA) standards and is accessible only by secured login membership.
Confidential center specific data: Centers' outcomes will be individually analyzed in a first step to screen for center-specific differences. Benchmarks will be computed from each center's results in a second step. No center-specific data will be published. Instead, all complications or adverse outcomes will be anonymously reported, as fractions of the total study population. Each center, of course, will be free to publish their own data, as they wish.
Further use of cohort data: Future studies based on the collected data may emerge from this multicenter study, such as comparing outcomes in patients with or without specific comorbidities with benchmark outcomes. For further data usage, additional ethics approval may be required.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
University Hospital Zurich
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
St Pierre University Hospital, Brussels, Belgium
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Sana Klinikum, Offenbach, Germany
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Complutense University of Madrid, Spain
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Musgrove Park Hospital, Taunton, UK
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
University of Gothenburg, Sweden
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
AZ Sint-Jan Hospital in Bruges, Belgium
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Bristol
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Cleveland Clinic, Weston, Florida, USA
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Oswaldo Cruz German Hospital, Sao Paolo, Brazil
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Clínica Las Condes, Santiago, Chile
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Brown University, Providence Rhode Island
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Fresno Bariatric, CA, USA
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Rijnstate Hospital, Arnhem, The Netherlands
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
CHU Nice, France
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Claraspital Basel, Switzerland
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Gastro-Obeso-Center Advanced Med Inst, Brazil
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Hospital Dipreca Santiago Región Metropolitana , Chile
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Medical University Wien, Austria
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bariatric surgery (RYGB or SG)
laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Primary laparoscopic/robotic proximal Roux-en-Y gastric bypass or sleeve gastrectomy
* Documented follow-up of at least 90 days
* Open surgery
* Previous intra-abdominal surgery (including previous bariatric surgery)
* Pre-operative BMI over 50 kg/m2
* Age over 65 years
* Cardiovascular disease (e.g. cardiac arrhythmia, stroke, coronary artery disease) (Hypertension is allowed)
* History of thromboembolic events and/or therapeutic anticoagulation
* Diabetes mellitus (Type I and Type II, as defined by the American Diabetes Association)
* Obstructive sleep apnea (recurrent episodes of upper airway collapse during sleep)
* Chronic obstructive pulmonary disease (FEV1/FVC\<0.7)
* Chronic kidney disease (eGFR \< 30ml/min/1.72 m2)
* Inflammatory bowel disease (ulcerative colitis, Crohn's)
* Immunosuppression therapy (e.g. steroids, calcineurin inhibitors, etc)
* Patients who underwent associated procedures (for example: cholecystectomy, hiatoplasty, liver biopsy)
* ASA score \> 2
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. med. Daniel Gero
UNKNOWN
Dr. med. Dimitri A. Raptis, PhD
UNKNOWN
Dr. med. Henner Schmidt
UNKNOWN
Marco Bueter
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marco Bueter
Prof. Dr. med., PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rossler F, Sapisochin G, Song G, Lin YH, Simpson MA, Hasegawa K, Laurenzi A, Sanchez Cabus S, Nunez MI, Gatti A, Beltrame MC, Slankamenac K, Greig PD, Lee SG, Chen CL, Grant DR, Pomfret EA, Kokudo N, Cherqui D, Olthoff KM, Shaked A, Garcia-Valdecasas JC, Lerut J, Troisi RI, De Santibanes M, Petrowsky H, Puhan MA, Clavien PA. Defining Benchmarks for Major Liver Surgery: A multicenter Analysis of 5202 Living Liver Donors. Ann Surg. 2016 Sep;264(3):492-500. doi: 10.1097/SLA.0000000000001849.
Muller X, Marcon F, Sapisochin G, Marquez M, Dondero F, Rayar M, Doyle MMB, Callans L, Li J, Nowak G, Allard MA, Jochmans I, Jacskon K, Beltrame MC, van Reeven M, Iesari S, Cucchetti A, Sharma H, Staiger RD, Raptis DA, Petrowsky H, de Oliveira M, Hernandez-Alejandro R, Pinna AD, Lerut J, Polak WG, de Santibanes E, de Santibanes M, Cameron AM, Pirenne J, Cherqui D, Adam RA, Ericzon BG, Nashan B, Olthoff K, Shaked A, Chapman WC, Boudjema K, Soubrane O, Paugam-Burtz C, Greig PD, Grant DR, Carvalheiro A, Muiesan P, Dutkowski P, Puhan M, Clavien PA. Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results. Ann Surg. 2018 Mar;267(3):419-425. doi: 10.1097/SLA.0000000000002477.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae.
Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien PA. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013 Jul;258(1):1-7. doi: 10.1097/SLA.0b013e318296c732.
Gero D, Raptis DA, Vleeschouwers W, van Veldhuisen SL, Martin AS, Xiao Y, Galvao M, Giorgi M, Benois M, Espinoza F, Hollyman M, Lloyd A, Hosa H, Schmidt H, Garcia-Galocha JL, van de Vrande S, Chiappetta S, Menzo EL, Aboud CM, Luthy SG, Orchard P, Rothe S, Prager G, Pournaras DJ, Cohen R, Rosenthal R, Weiner R, Himpens J, Torres A, Higa K, Welbourn R, Berry M, Boza C, Iannelli A, Vithiananthan S, Ramos A, Olbers T, Sepulveda M, Hazebroek EJ, Dillemans B, Staiger RD, Puhan MA, Peterli R, Bueter M. Defining Global Benchmarks in Bariatric Surgery: A Retrospective Multicenter Analysis of Minimally Invasive Roux-en-Y Gastric Bypass and Sleeve Gastrectomy. Ann Surg. 2019 Nov;270(5):859-867. doi: 10.1097/SLA.0000000000003512.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BASECnr_2017-01652
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.